WKY/NCrl |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
vehicle control condition (for 28 days) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
vasodilation trait |
male |
168 days
| 7 |
97.56 |
% |
1.02 |
2.7 |
wire myography |
|
0.0 |
0 |
103598 |
2827 |
GK |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
vehicle control condition (for 28 days) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
vasodilation trait |
male |
168 days
| 8 |
-7.39 |
null |
0.04 |
0.11 |
wire myography |
|
0.0 |
0 |
103604 |
2827 |
GK |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
vehicle control condition (for 28 days) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
vasodilation trait |
male |
168 days
| 8 |
96.96 |
% |
2.2 |
6.22 |
wire myography |
|
0.0 |
0 |
103608 |
2827 |
MWF/FubRkb |
norepinephrine-induced blood vessel contractile force expressed as percent of force of contraction to KCL |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
vasoconstriction trait |
male |
114 days
| 10 |
77.8 |
% |
10.2 |
32.26 |
wire myography |
|
0.0 |
0 |
109441 |
3140 |
MWF/FubRkb |
negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
vasoconstriction trait |
male |
114 days
| 10 |
6.9 |
null |
0.1 |
0.32 |
wire myography |
|
0.0 |
0 |
109445 |
3140 |
GK |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
vehicle control condition (for 28 days) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
vasodilation trait |
male |
168 days
| 8 |
-7.29 |
null |
0.09 |
0.26 |
wire myography |
|
0.0 |
0 |
103588 |
2827 |
GK |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
vehicle control condition (for 28 days) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
vasodilation trait |
male |
168 days
| 8 |
94.07 |
% |
1.13 |
3.18 |
wire myography |
|
0.0 |
0 |
103600 |
2827 |
GK |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
vehicle control condition (for 28 days) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
vasodilation trait |
male |
168 days
| 8 |
-8.74 |
null |
0.57 |
1.61 |
wire myography |
|
0.0 |
0 |
103612 |
2827 |
Crl:WI |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
vasodilation trait |
male |
114 days
| 10 |
90.3 |
% |
1.2 |
3.79 |
wire myography |
mesenteric artery |
0.0 |
0 |
109431 |
3140 |
Crl:WI |
negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
vasoconstriction trait |
male |
114 days
| 10 |
6.7 |
null |
0.1 |
0.32 |
wire myography |
|
0.0 |
0 |
109443 |
3140 |
GK |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
vehicle control condition (for 28 days) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
vasodilation trait |
male |
168 days
| 8 |
86.87 |
% |
3.06 |
8.65 |
wire myography |
|
0.0 |
0 |
103616 |
2827 |
GK |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
vehicle control condition (for 28 days) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
vasodilation trait |
male |
168 days
| 8 |
67.1 |
% |
3.32 |
9.39 |
wire myography |
|
0.0 |
0 |
103592 |
2827 |
WKY/NCrl |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
vehicle control condition (for 28 days) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
vasodilation trait |
male |
168 days
| 7 |
99.75 |
% |
2.32 |
6.14 |
wire myography |
|
0.0 |
0 |
103606 |
2827 |
WKY/NCrl |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
vehicle control condition (for 28 days) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
vasodilation trait |
male |
168 days
| 7 |
-8.15 |
null |
0.09 |
0.24 |
wire myography |
|
0.0 |
0 |
103610 |
2827 |
WKY/NCrl |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
vehicle control condition (for 28 days) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
vasodilation trait |
male |
168 days
| 7 |
-7.07 |
null |
0.05 |
0.14 |
wire myography |
|
|
0 |
103586 |
2827 |
WKY/NCrl |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
vehicle control condition (for 28 days) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
vasodilation trait |
male |
168 days
| 7 |
89.88 |
% |
2.56 |
6.77 |
wire myography |
|
0.0 |
0 |
103590 |
2827 |
WKY/NCrl |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
vehicle control condition (for 28 days) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
vasodilation trait |
male |
168 days
| 7 |
-8.06 |
null |
0.05 |
0.13 |
wire myography |
|
0.0 |
0 |
103594 |
2827 |
GK |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
vehicle control condition (for 28 days) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
vasodilation trait |
male |
168 days
| 8 |
-7.96 |
null |
0.05 |
0.14 |
wire myography |
|
0.0 |
0 |
103596 |
2827 |
WKY/NCrl |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
vehicle control condition (for 28 days) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
vasodilation trait |
male |
168 days
| 7 |
-7.6 |
null |
0.05 |
0.13 |
wire myography |
|
0.0 |
0 |
103602 |
2827 |
WKY/NCrl |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
vehicle control condition (for 28 days) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
vasodilation trait |
male |
168 days
| 7 |
96.54 |
% |
1.9 |
5.03 |
wire myography |
|
0.0 |
0 |
103614 |
2827 |
MWF/FubRkb |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
vasodilation trait |
male |
114 days
| 10 |
82.3 |
% |
3.0 |
9.49 |
wire myography |
mesenteric artery |
0.0 |
0 |
109433 |
3140 |
Crl:WI |
norepinephrine-induced blood vessel contractile force expressed as percent of force of contraction to KCL |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
vasoconstriction trait |
male |
114 days
| 10 |
51.3 |
% |
4.7 |
14.86 |
wire myography |
|
0.0 |
0 |
109439 |
3140 |